The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125620411 12562041 1 I 20160630 20160715 20160715 EXP NL-WEST-WARD PHARMACEUTICALS CORP.-NL-H14001-16-01301 WESTWARD VAN AALST J,TEERNSTRA O,WEBER W,RIJKERS K. AN UNUSUAL CASE OF POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME IN A PATIENT BEING WEANED FROM INTRATHECAL MORPHINE. INTERNATIONAL MEDICAL CASE REPORTS JOURNAL 2016;9:117-120. 63.00 YR F Y 0.00000 20160715 MD NL NL

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125620411 12562041 1 PS CO-AMOXICLAV AMOXICILLINCLAVULANIC ACID 1 Unknown 65191
125620411 12562041 2 SS CO-AMOXICLAV AMOXICILLINCLAVULANIC ACID 1 Intravenous (not otherwise specified) 65191 200 MG QID
125620411 12562041 3 SS DIAZEPAM APOTEX, TABLETTEN DIAZEPAM 1 Oral 0 5 MG TID
125620411 12562041 4 SS AMITRIPTYLINE HCL APOTEX TABLETTEN AMITRIPTYLINE 1 Unknown 0
125620411 12562041 5 SS AMITRIPTYLINE HCL APOTEX TABLETTEN AMITRIPTYLINE 1 Unknown 0
125620411 12562041 6 SS MORPHINE MORPHINE 1 Intrathecal 0
125620411 12562041 7 SS MORPHINE MORPHINE 1 Intrathecal 0 .5 MG
125620411 12562041 8 SS MORPHINE MORPHINE 1 Intrathecal 0 .5 MG
125620411 12562041 9 SS CLINDAMYCIN CLINDAMYCINCLINDAMYCIN PHOSPHATE 1 Unknown 0 300 MG QID
125620411 12562041 10 SS CLONIDINE. CLONIDINE 1 Oral 0 .15 MG TID
125620411 12562041 11 SS OXYCONTIN OXYCODONE HYDROCHLORIDE 1 Oral 0 20 MG QID
125620411 12562041 12 SS DUROGESIC FENTANYL 1 Transdermal 0 100 UG
125620411 12562041 13 SS SEVOFLURANE. SEVOFLURANE 1 Unknown 0
125620411 12562041 14 SS PROPOFOL. PROPOFOL 1 Unknown 0
125620411 12562041 15 SS SUFENTANIL SUFENTANIL 1 Unknown 0
125620411 12562041 16 SS ROCURONIUM ROCURONIUM BROMIDE 1 Unknown 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125620411 12562041 1 Product used for unknown indication
125620411 12562041 3 Muscle spasms
125620411 12562041 4 Amputation stump pain
125620411 12562041 6 Amputation stump pain
125620411 12562041 9 Product used for unknown indication
125620411 12562041 10 Analgesic therapy
125620411 12562041 11 Analgesic therapy
125620411 12562041 12 Analgesic therapy
125620411 12562041 13 General anaesthesia
125620411 12562041 14 General anaesthesia
125620411 12562041 15 General anaesthesia
125620411 12562041 16 General anaesthesia

Outcome of event

Event ID CASEID OUTC COD
125620411 12562041 HO
125620411 12562041 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
125620411 12562041 Hemiparesis
125620411 12562041 Off label use
125620411 12562041 Posterior reversible encephalopathy syndrome

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found